Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Active Biotech's Laquinimod Fails to Meet Primary Endpoint in Phase II Trial November 30, 2017 Pfizer Sheds More After Unloading Medivation's Mission Bay Space May 8, 2017 Bay Area's Zogenix Explodes on Late-Stage Epilepsy Data September 28, 2017